agilon health, inc.
AGL
$86.39
$5.827.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -244.34M | -281.14M | -198.05M | -315.66M | -241.98M |
| Total Depreciation and Amortization | 7.38M | 7.46M | 10.19M | 16.41M | 15.00M |
| Total Amortization of Deferred Charges | 13.70M | 13.70M | 10.50M | 10.50M | 10.50M |
| Total Other Non-Cash Items | 64.25M | 75.62M | 6.86M | 18.42M | 19.36M |
| Change in Net Operating Assets | 127.11M | 96.75M | 119.85M | 211.98M | 155.13M |
| Cash from Operations | -31.89M | -87.61M | -50.65M | -58.36M | -41.99M |
| Capital Expenditure | -9.32M | -10.07M | -10.37M | -13.90M | -13.96M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 121.63M | 80.02M | 81.41M | 131.50M | 79.33M |
| Cash from Investing | 112.31M | 69.95M | 71.04M | 117.61M | 65.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.50M | -- | 0.00 | -1.25M | -2.50M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -22.00K | -178.00K | -642.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.24M | -2.76M | -2.74M | -2.74M | -161.00K |
| Cash from Financing | -7.74M | -2.76M | -2.76M | -4.17M | -3.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.68M | -20.42M | 17.63M | 55.08M | 20.07M |